Bank Of America Corp Edwards Lifesciences Corp Put Options Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $7.5 Million - $8.39 Million	-89,000 Reduced 71.77%	35,000 $3.23 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $7.54 Million - $9.94 Million	104,000 Added 520.0%	124,000 $11.8 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $14.2 Million - $17.9 Million	-230,000 Reduced 92.0%	20,000 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $20.4 Million - $23.6 Million	250,000 New	250,000 $23.6 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $2.15 Million - $3.19 Million	24,900 Added 184.44%	38,400 $3.65 Million
Q4 2021 Feb 08, 2022	SELL	$106.37 - $130.68 $180,829 - $222,156	-1,700 Reduced 11.18%	13,500 $1.75 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $10.1 Million - $12.1 Million	-98,300 Reduced 86.61%	15,200 $1.72 Million
Q2 2021 Sep 13, 2021	BUY	$83.84 - $104.76 $9.52 Million - $11.9 Million	113,500 New	113,500 $11.8 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.